Late Phase 2 Double-Blind Study to Assess the Dose-Response of JTZ-951 in Anemic Patients with Chronic Kidney Disease Receiving Maintenance Hemodialysis <Switch / Maintenance Study>
Phase of Trial: Phase II
Latest Information Update: 02 Feb 2017
At a glance
- Drugs JTZ 951 (Primary)
- Indications Anaemia
- Focus Therapeutic Use
- Sponsors Japan Tobacco
- 18 Jan 2017 Status changed from active, no longer recruiting to completed.
- 16 Jun 2016 New trial record
- 19 Feb 2016 Status changed from recruiting to active, no longer recruiting.